Evidence map›Paper›PMID 35186896›Full record

ArticleFrontiers in chemistry2021

Synthesis and Antitumor Evaluation of Menthone-Derived Pyrimidine-Urea Compounds as Potential PI3K/Akt/mTOR Signaling Pathway Inhibitor.

Mei Huang, Wengui Duan, Naiyuan Chen, Guishan Lin, Xiu Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Investigating the Health Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. The role of PI3K signaling pathway in Alzheimer's disease.Frontiers in aging neuroscience · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mei HuangSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning, China.
Wengui DuanSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning, China.
Naiyuan ChenSchool of Public Health, Guangxi Medical University, Nanning, China.
Guishan LinSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning, China.
Xiu WangSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning, China.
Guangxi University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel menthone derivatives bearing pyrimidine and urea moieties was designed and synthesized to explore more potent natural product-derived antitumor agents. The structures of the target compounds were confirmed by FTIR, NMR, and HRMS. The

Indexed as

antitumor activitymenthonePI3K/AKT/mTORpyrimidinesynthesisurea

Identifiers

PMID35186896
PMCPMC8852737
OpenAlexW4212959817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.